Recent Articles

• 
  MedTech

  "AI Detects Parkinson's Early, Treats with Light"

  Domestic researchers have discovered a new possibility for the early diagnosis and treatment of Parkinson's disease using artificial intelligence (AI) and optogenetics technology. A joint research team led by Professor Kim Dae-soo of KAIST and Director Lee Chang-jun of the Institute for Basic Scienc

  2025.09.23
• 
  Medical / Research

  GC Green Cross Seeks Phase 1 Trial for COVID-19 Vaccine

  GC Green Cross Headquarters GC Green Cross announced on the 22nd that it has submitted a domestic Phase 1 clinical trial plan (IND) for the COVID-19 mRNA (messenger ribonucleic acid) vaccine candidate 'GC4006A' to the Ministry of Food and Drug Safety (MFDS).The development of the COVID-19 vaccine ca

  2025.09.22
• 
  Medical / Research

  Celltrion's Autoimmune Drug Approved in Japan

  Celltrion AVTOZMACelltrion announced on the 22nd that its biosimilar product 'AVTOZMA' (ingredient name: tocilizumab), a treatment for autoimmune diseases, has received product approval from Japan's Ministry of Health, Labour and Welfare. Through this approval, AVTOZMA has been authorized for major

  2025.09.22
• 
  Medical / Pharmaceutical

  Korean United Pharm Marks 38th Anniversary, CEO Pledges Growth

  Kang Deok-young, CEO of Korea United Pharm, and employees. Korea United Pharm announced on the 22nd that it held a commemorative event with the participation of all employees to celebrate its 38th anniversary and to encourage the members who have contributed to the company's growth.The event, held o

  2025.09.22
• 
  Medical / Research

  Inha Hospital Innovates Kidney, Bladder Cancer Surgery

  Professor Jung Doo-yong of the Department of Urology at Inha University Hospital (left) is performing a 'docking' procedure to connect a patient with a surgical robot before a bladder resection robotic surgery. Provided by Inha University HospitalMr. Kim (64), who has long suffered from diabetes and

  2025.09.22
• 
  Medical / Pharmaceutical

  Celltrion Launches Urticaria Drug Omariqlo in Europe

  Celltrion OmricloCelltrion's chronic idiopathic urticaria treatment 'Omriclo (ingredient name: omalizumab)' has been officially launched in the European market.Celltrion announced on the 19th that it has launched Omriclo in Norway, a major Northern European country, and has commenced full-scale sale

  2025.09.19
• 
  Biohealth / Smart Manufacturing

  Jongkundang Adopts AI System to Boost Production

  Kim Young-joo, CEO of Chong Kun Dang, delivers a speech at the 2025 Autonomous Factory Establishment Project launch ceremony. Chong Kun Dang is introducing an artificial intelligence (AI) control system at its Cheonan plant in Chungnam, marking the first such implementation in the domestic pharmaceu

  2025.09.19
• 
  Medical / Research

  Jefit Chosen for Korea's ARPA-H Project

  Zebrafish-based personalized drug testing company Zefit (CEO Lee Ki-baek) announced that it has been finally selected as a joint research institution for the 'Korean ARPA-H Project' research task, organized by the Ministry of Health and Welfare and the Korea Health Industry Development Institute's K

  2025.09.19
• 
  Medical / Biomanufacturing

  Yuhan Begins Construction on New Osong Plant

  Yuhan Corporation Osong New Plant Groundbreaking Ceremony.Yuhan Corporation announced on the 19th that it held a groundbreaking ceremony for its new plant at the Osong 2nd Life Science Complex in Cheongju, Chungbuk on the 18th. The event was attended by key figures including Yuhan Corporation employ

  2025.09.19
• 
  Medical / Research

  "Oral Bacteria Triple Pancreatic Cancer Risk"

  Photo = Getty Images Korea. Pancreatic cancer is known as the 'silent killer' due to the difficulty of early detection. The prognosis is poor, with a 5-year survival rate of only about 10% after diagnosis.However, a new study published in the Journal of the American Medical Association (JAMA) Oncolo

  2025.09.19